GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $16,964,000 | +119.3% | 249,107 | +2.9% | 0.03% | +133.3% |
Q2 2022 | $7,736,000 | -17.3% | 242,142 | -9.5% | 0.01% | 0.0% |
Q1 2022 | $9,349,000 | +97.9% | 267,482 | +65.8% | 0.01% | +100.0% |
Q4 2021 | $4,723,000 | +79.7% | 161,346 | +56.4% | 0.01% | +50.0% |
Q3 2021 | $2,628,000 | -12.0% | 103,138 | +20.9% | 0.00% | 0.0% |
Q2 2021 | $2,987,000 | +45.8% | 85,305 | +69.7% | 0.00% | +33.3% |
Q1 2021 | $2,048,000 | -44.0% | 50,265 | -40.4% | 0.00% | 0.0% |
Q4 2020 | $3,656,000 | -22.2% | 84,392 | +2.4% | 0.00% | -62.5% |
Q3 2020 | $4,698,000 | +38.3% | 82,421 | +53.2% | 0.01% | +33.3% |
Q2 2020 | $3,397,000 | +76.9% | 53,802 | +60.9% | 0.01% | +50.0% |
Q1 2020 | $1,920,000 | -22.9% | 33,442 | +6.8% | 0.00% | 0.0% |
Q4 2019 | $2,490,000 | +61.3% | 31,327 | 0.0% | 0.00% | +33.3% |
Q3 2019 | $1,544,000 | -2.0% | 31,327 | +4.5% | 0.00% | 0.0% |
Q2 2019 | $1,576,000 | +8.3% | 29,967 | +9.0% | 0.00% | 0.0% |
Q1 2019 | $1,455,000 | – | 27,485 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |